| Literature DB >> 35032306 |
Atefeh Ameri1, Fahimeh Asadi2, Mojtaba Shakibaie1,3, Alieh Ameri4, Hamid Forootanfar5,6, Mehdi Ranjbar7.
Abstract
The hydroxyapatite/glycyrrhizin/lithium-based metal-organic framework (HA/GL/Li-MOF) nanocomposites were synthesized via the hydrothermal method in the presence of lecithin and glycyrrhizin. Fourier transform infrared (FTIR) spectroscopy, thermogravimetric analysis (TGA), and scanning electron microscopy (SEM) equipped with energy-dispersive X-ray spectroscopy (EDS) were applied for characterization of the fabricated nanocomposites. The HA/GL/Li-MOF and Li-MOF nanocomposites were employed as support for immobilization of Thermomyces lanuginosus lipase (TLL). The Plackett-Burman and Box-Behnken designs were used for screening and optimizing of variables affecting the immobilization conditions, respectively. The optimum specific activity of immobilized TLL on HA/GL/Li-MOF and Li-MOF nanocomposites (41.8 ± 1.2 U/mg and 39.4 ± 3.1 U/mg, respectively) was predictably determined at support concentration of 0.5 mg/mL, glutaraldehyde concentration of 5 mM, and enzyme activity of 20 U/mg, while the specific activities of TLL@ HA/GL/Li-MOF and TLL@Li-MOF were experimentally found to be 39.5 ± 3.7 U/mg and 38.5 ± 2.3 U/mg, respectively. The stability results showed that the TLL@ HA/GL/Li-MOF has suitable stability against pH and thermal denaturation. However, the immobilized TLL on Li-MOF represented lower stability compared with that of the HA/GL/Li-MOF. The immobilized TLL on HA/GL/Li-MOF maintained near 70% of its original activity after 15 days' storage and during 5 runs of application. In addition, TLL@HA/GL/Li-MOF exhibited higher enzyme-substrate affinity (Km, 10.1 mM) compared to that of TLL@Li-MOF (Km, 23.4 mM). Therefore, these findings demonstrated the potential use of HA/GL/Li-MOF nanocomposites for enzyme immobilization.Entities:
Keywords: Box-Behnken design; Hydroxyapatite; Lipase immobilization; Specific activity; Thermomyces lanuginosus
Mesh:
Substances:
Year: 2022 PMID: 35032306 DOI: 10.1007/s12010-022-03800-3
Source DB: PubMed Journal: Appl Biochem Biotechnol ISSN: 0273-2289 Impact factor: 2.926